Trademark: 97166118
Status Date
Monday, December 18, 2023
Filing Date
Friday, December 10, 2021
Published for Opposition
Tuesday, March 15, 2022
Abandoned Date
Monday, December 18, 2023
5 Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of alopecia areata, vitiligo, inflammatory bowel disease, ulcerative colitis, and Crohn's disease
The mark consists of a circle in the center surrounded by two overlapping curved lines on one side and two overlapping curved lines on the other side.
Color is not claimed as a feature of the mark.
Dec 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 18, 2023
Abandonment - No Use Statement Filed
Apr 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Sou Extension 2 Granted
Apr 17, 2023
Sou Extension 2 Filed
Apr 17, 2023
Sou Teas Extension Received
Mar 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 28, 2023
Teas Change Of Correspondence Received
Mar 28, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 28, 2023
Teas Change Of Owner Address Received
Oct 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2022
Sou Extension 1 Granted
Oct 17, 2022
Sou Extension 1 Filed
Oct 17, 2022
Sou Teas Extension Received
May 10, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 4, 2022
Approved For Pub - Principal Register
Feb 3, 2022
Assigned To Examiner
Dec 16, 2021
Notice Of Design Search Code E-Mailed
Dec 15, 2021
New Application Office Supplied Data Entered
Dec 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
